首页> 外文期刊>Stem cells international >Bone Tissue Regeneration in the Oral and Maxillofacial Region: A Review on the Application of Stem Cells and New Strategies to Improve Vascularization
【24h】

Bone Tissue Regeneration in the Oral and Maxillofacial Region: A Review on the Application of Stem Cells and New Strategies to Improve Vascularization

机译:口腔和颌面区域中的骨组织再生:对干细胞的应用和新策略改善血管化的综述

获取原文
           

摘要

Bone tissue engineering techniques are a promising alternative for the use of autologous bone grafts to reconstruct bone defects in the oral and maxillofacial region. However, for successful bone regeneration, adequate vascularization is a prerequisite. This review presents and discusses the application of stem cells and new strategies to improve vascularization, which may lead to feasible clinical applications. Multiple sources of stem cells have been investigated for bone tissue engineering. The stromal vascular fraction (SVF) of human adipose tissue is considered a promising single source for a heterogeneous population of essential cells with, amongst others, osteogenic and angiogenic potential. Enhanced vascularization of tissue-engineered grafts can be achieved by different mechanisms: vascular ingrowth directed from the surrounding host tissue to the implanted graft, vice versa, or concomitantly. Vascular ingrowth into the implanted graft can be enhanced by (i) optimizing the material properties of scaffolds and (ii) their bioactivation by incorporation of growth factors or cell seeding. Vascular ingrowth directed from the implanted graft towards the host tissue can be achieved by incorporating the graft with either (i) preformed microvascular networks or (ii) microvascular fragments (MF). The latter may have stimulating actions on both vascular ingrowth and outgrowth, since they contain angiogenic stem cells like SVF, as well as vascularized matrix fragments. Both adipose tissue-derived SVF and MF are cell sources with clinical feasibility due to their large quantities that can be harvested and applied in a one-step surgical procedure. During the past years, important advancements of stem cell application and vascularization in bone tissue regeneration have been made. The development of engineered in vitro 3D models mimicking the bone defect environment would facilitate new strategies in bone tissue engineering. Successful clinical application requires innovative future investigations enhancing vascularization.
机译:骨组织工程技术是使用自体骨移植物来重建口腔和颌面区域中的骨缺陷的有希望的替代方案。然而,对于成功的骨再生,足够的血管形成是先决条件。本综述提出并讨论了干细胞和新策略的应用,以改善血管化,这可能导致可行的临床应用。对骨组织工程研究了多种干细胞来源。人脂肪组织的基质血管级分(SVF)被认为是具有骨质植物和血管生成潜力的非均相基本细胞的非均相群体的有希望的单一来源。通过不同的机制可以实现组织工程移植物的增强血管化:从周围的宿主组织向植入移植物,反之亦然,或伴随地,可以实现组织工程移植物的血管化。通过(i)通过掺入生长因子或细胞播种,可以通过(i)通过(i)通过(i)通过(i)优化它们的生物活化的材料特性,并通过掺入生长因子或细胞播种来增强血管生长进入植入移植物。通过将移植物掺入(I)预先成形的微血管网络(II)微血管片段(MF),可以通过将移植物掺入朝向宿主组织的血管向期朝​​向宿主组织来实现。后者可能具有刺激血管生长和过度的动作,因为它们含有血管生成干细胞,如SVF,以及血管化基质片段。脂肪组织衍生的SVF和MF都是细胞源,其由于它们在一步手术过程中可以收获并施加的大量而具有临床可行性。在过去几年中,已经进行了干细胞施用和骨组织再生血管化的重要进步。模仿骨缺损环境模仿的体外3D模型的设计的发展将促进骨组织工程中的新策略。成功的临床应用需要创新的未来调查,增强血管化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号